Astellas Pharma buying Universal Cells for $102M in Seattle’s third biotech acquisition in a month Astellas Pharma, a Japanese pharmaceutical and biotechnology company, is acquiring Seattle biotech Universal Cells. Astellas will pay up to $102.5… Read More
